Hong Kong Pharma Digital Technology Holdings Ltd
HKPD$15M
Micro CapNASDAQWholesale-Drugs, Proprietaries & Druggists' Sundries🇺🇸North AmericaKOWLOON27 employees
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Dec 31, 2026
35wMarket Overview
Stock performance and key metrics
HKPD News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
EI-001
Non-segmental Vitiligo
INS018_055
Idiopathic Pulmonary Fibrosis (IPF)
EI-1071 tablet, oral
Mild, Moderate, or Severe Alzheimer's Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
EI-001 | Phase 2 | Non-segmental Vitiligo | - | - |
INS018_055 | Phase 2 | Idiopathic Pulmonary Fibrosis (IPF) | - | - |
EI-1071 tablet, oral | Phase 2 | Mild, Moderate, or Severe Alzheimer's Disease | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply